Predict your next investment

Corporation
HEALTHCARE | Healthcare Plans
healthnet.com

See what CB Insights has to offer

Investments

14

Partners & Customers

10

About Health Net

Health Net provides and administers health benefits through group, individual, Medicare (including the Medicare prescription drug benefit commonly referred to as "Part D"), Medicaid and dual eligible programs. Health Net also offers access to behavioral health, substance abuse and employee assistance programs, and managed health care products related to prescription drugs.

Health Net Headquarter Location

21650 Oxnard Street

Woodland Hills, California, 91367,

United States

818-676-6000

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Health Net News

Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.

Nov 15, 2021

USA Inc., No. )  Drug Product and Patent(s)-in-Suit: Vascepa® (icosapent ethyl); U.S. Patents Nos. 9,700,537 (“the ’537 patent”), 8,642,077 (“the ’077 patent”), 10,568,861 (“the ’861 patent”) Nature of Case and Issue(s) Presented:  The patents-in-suit cover methods of using icosapent ethyl to reduce the risk of cardiovascular events in patients. Vascepa currently has two FDA-approved indications: (i) treatment of severe hypertriglyceridemia (the “SH indication”); and (ii) cardiovascular risk reduction (the “CV indication”). Hikma launched a generic version of Vascepa after receiving FDA approval of its ANDA with a “section viii” carve out regarding the patents-in-suit. That is, Hikma represented to the FDA that it would not market its generic product for the uses covered by the patents-in-suit, which at the time of the filing of Hikma’s ANDA, was only the SH indication. But by the time Hikma’s product hit the market, the majority of doctors who prescribed Vascepa did so for uses other than the SH indication, including the CV indication. Amarin alleged that Hikma was aware of that fact and promoted the administration of its product in a way that infringed the patents-in-suit. Moreover, it alleged that insurance provider Health Net was aware that use of Hikma’s generic for the CV indication infringed the patents-in-suit. That was because Health Net’s plans required “Prior Authorization” before it would cover and pay for either Vascepa or Hikma’s generic version, and a medical provider was required to indicate whether the prescription was being given for either the SH or CV indication. Amarin also alleged that Health Net encouraged the use of the allegedly infringing generic by requiring a higher co-pay for Vascepa. Health Net filed a motion to dismiss. Despite acknowledging “[n]either side has cited any case in which a health insurer has been found liable to a pharmaceutical company for inducing infringement of a drug method of use patent,” the court recommended denying Health Net’s motions to dismiss. Why Amarin Prevailed: The court noted that: (i) Health Net might not have taken affirmative acts with the intent to cause infringement; (ii) Health Net’s formulary and pre-authorization actions might not influence providers to prescribe or beneficiaries to use the generic product in an infringing way; or (iii) the plaintiffs’ own pricing decisions might encourage the use of the generic product over the branded product. But the court found that the pleadings stage was an inappropriate time to assess whether Health Net’s approval and payment process affected physicians’ prescription decisions. Since the court must view the allegations in the light most favorable to Amarin at the motion to dismiss stage, the court found Amarin’s claims plausible. While Amarin’s novel inducement theory survived the plausibility standard for pleadings, ANDA holders and third-party insurance providers will have to wait to see how the infringement case pans out as the case moves forward.

Health Net Investments

14 Investments

Health Net has made 14 investments. Their latest investment was in Cherished Futures as part of their Grant on April 4, 2021.

CBI Logo

Health Net Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/22/2021

Grant

Cherished Futures

$0.3M

Yes

2

9/23/2019

Grant

Community Medical Centers

Yes

1

9/23/2019

Grant

Family HealthCare Network

Yes

1

9/23/2019

Grant

Subscribe to see more

$99M

Subscribe to see more

10

9/23/2019

Grant

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/22/2021

9/23/2019

9/23/2019

9/23/2019

9/23/2019

Round

Grant

Grant

Grant

Grant

Grant

Company

Cherished Futures

Community Medical Centers

Family HealthCare Network

Subscribe to see more

Subscribe to see more

Amount

$0.3M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

1

1

10

10

Health Net Partners & Customers

10 Partners and customers

Health Net has 10 strategic partners and customers. Health Net recently partnered with Canopy Health on September 9, 2020.

Date

Type

Business Partner

Country

News Snippet

Sources

9/17/2020

Partner

Canopy Health

United States

1

9/4/2019

Partner

Canopy Health

United States

Canopy Health Set to Expand Health Net Smart Care

Incorporated in March 2015 as an affiliation between UCSF Health and John Muir Health , Canopy Health aims to provide a top-quality continuum of care across the Bay Area through partnerships with primary care providers , top-tier academic medical facilities , community hospitals , and medical groups .

1

11/8/2018

Partner

Sacramento City College, Greater Sacramento Urban League, and WellSpace Health

United States

Nestlé Waters' Cabazon Plant Installs Third Wind Turbine

In addition to these milestones in Cabazon , earlier this year , Nestlé Waters announced a partnership with the Sacramento Municipal Utility District for its factory in Sacramento , California to be powered by 100 percent renewable energy .

2

3/13/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

1/1/2018

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

9/17/2020

9/4/2019

11/8/2018

3/13/2018

1/1/2018

Type

Partner

Partner

Partner

Partner

Partner

Business Partner

Canopy Health

Canopy Health

Sacramento City College, Greater Sacramento Urban League, and WellSpace Health

Country

United States

United States

United States

Subscribe to see more

Subscribe to see more

News Snippet

Canopy Health Set to Expand Health Net Smart Care

Incorporated in March 2015 as an affiliation between UCSF Health and John Muir Health , Canopy Health aims to provide a top-quality continuum of care across the Bay Area through partnerships with primary care providers , top-tier academic medical facilities , community hospitals , and medical groups .

Nestlé Waters' Cabazon Plant Installs Third Wind Turbine

In addition to these milestones in Cabazon , earlier this year , Nestlé Waters announced a partnership with the Sacramento Municipal Utility District for its factory in Sacramento , California to be powered by 100 percent renewable energy .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

1

2

10

10

Health Net Team

15 Team Members

Health Net has 15 team members, including former Chief Executive Officer, President, Steven Sell.

Name

Work History

Title

Status

Steven Sell

Chief Executive Officer, President

Former

Artie Southam MD

Chief Executive Officer, President

Former

Mark El Tawil

President, Chief Product Officer

Former

Douglas King

President, Chief Financial Officer, Senior Vice President

Former

Cora M Tellez

President

Former

Name

Steven Sell

Artie Southam MD

Mark El Tawil

Douglas King

Cora M Tellez

Work History

Title

Chief Executive Officer, President

Chief Executive Officer, President

President, Chief Product Officer

President, Chief Financial Officer, Senior Vice President

President

Status

Former

Former

Former

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.